Gilead, Galapagos amend commercialisation and development pact for Jyseleca (filgotinib)
Under the new arrangement, Galapagos will assume sole responsibility in Europe for filgotinib in RA, Gilead to receive royalties…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Filgotinib
Gilead gets approval for Jyseleca (filgotinib) in Japan for rheumatoid arthritis
Gilead Japan will hold marketing authorisation of Jyseleca in Japan while Eisai will be responsible for product distribution
US FDA declines approval for Gilead’s rheumatoid arthritis drug, Filgotinib
The US drug regulator has issued a complete response letter requesting data from the MANTA and MANTA-RAy studies and expressing…
Higher dose of Gilead-Galapagos drug meets ulcerative colitis study goals
Filgotinib is also in advanced stages of testing against multiple types of inflammatory conditions including rheumatoid arthritis,…